Grants for Alzheimer Therapeutic Agent Testing in International
GrantID: 11113
Grant Funding Amount Low: $800,000
Deadline: Ongoing
Grant Amount High: $800,000
Summary
This grant is open to U.S. and international researchers directed towards Alzheimer’s and related dementias. Applications accepted from academic investigators and small companies with lead candidate therapeutic agents that require early stage testing or that have already established human safety data and require a small-scale pilot Proof of Mechanism (POM) study in humans.
Organizations and individuals based in International who are engaged in Other may be eligible to apply for this funding opportunity. To discover more grants that align with your mission and objectives, visit The Grant Portal and explore listings using the Search Grant tool.
Eligible Regions
Interests
Eligible Requirements